Method For Guidance Of Fluid Therapy Based On Proadrenomedullin


The invention relates to a method of therapy guidance, stratification and/or monitoring of fluid therapy based on proadrenomedullin (pro ADM) levels. The invention therefore relates to a method for therapy guidance, stratification and/or monitoring of a fluid therapy, comprising providing a sample of said patient, determining a level of pro adrenomedullin (pro ADM) or fragment(s) thereof in said sample, wherein said level of pro ADM or fragment(s) thereof indicates the prescription of fluid therapy to be administered to the patient. The invention further relates to methods for guiding fluid therapy volume and to methods of treating disease using fluid therapy based on the pro ADM stratification of patients based on the methods described herein.


Download Citation

Sign in to the Lens